Skip to main content

Advertisement

SpringerLink
Log in

CXCL12-3′A Polymorphism and lung cancer metastases protection: new perspectives in immunotherapy?

  • Original Article
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Balkwill F (2004) Cancer and the chemokine network. Nat Rev Cancer 4:540–550

    Article  PubMed  CAS  Google Scholar 

  2. Benovic JL, Marchese A (2004) A new key in breast cancer metastases. Cancer Cell 6:429–430

    Article  PubMed  CAS  Google Scholar 

  3. Epstein RJ (2004) The CXCL12-CXCR4 chemotactic pathway as a target of adjuvant breast cancer therapies. Nat Rev Cancer 4:1–9

    Article  Google Scholar 

  4. Hart I, Fidler I (1980) Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Cancer Res 40:2281–2287

    PubMed  CAS  Google Scholar 

  5. Hoffman PC, Mauer AM, Vokes EE (2000) Lung cancer. Lancet 355:479–485

    PubMed  CAS  Google Scholar 

  6. Homey B, Muller A, Zlotnik A (2002) Chemokines: agents for the immunotherapy of cancer? Nat Rev Immunol 2:175–184

    Article  PubMed  CAS  Google Scholar 

  7. Kaplan E, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481

    Article  Google Scholar 

  8. Kristiansen B, Knudsen TB, Ohlendorff S, Eugen-Olsen J (2001) A new multiplex PCR strategy for the simultaneous determination of four genetic polymorphisms affecting HIV-1 disease progression. J Immunol Methods 252:147–151

    Article  PubMed  CAS  Google Scholar 

  9. Kucia M, Jankowski K, Reca R, Wysoczynski M, Bandura L, Allendorf DJ, Zhang J, Ratajczak J, Ratajczak MZ (2004) CXCR4–SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 35:233–245

    Article  PubMed  CAS  Google Scholar 

  10. Liotta LA (2001) An attractive force in metastasis. Nature 410:24–25

    Article  PubMed  CAS  Google Scholar 

  11. Miller S, Dykes D, Polesky H (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215

    Article  PubMed  CAS  Google Scholar 

  12. Minna JD, Roth JA, Gazdar AF (2002) Focus on lung cancer. Cancer Cell 1:49–52

    Article  PubMed  CAS  Google Scholar 

  13. Mochizuki H, Matsubara A, Teishima J, Mutaguchi K, Yasumoto H, Dahiya R, Usui T, Kamiya K (2004) Interaction of ligand–receptor system between stromal-cell derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis. Biochem Biophys Res Commun 320:656–663

    Article  PubMed  CAS  Google Scholar 

  14. Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verástegul E, Zlotnik A (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50–56

    Article  PubMed  Google Scholar 

  15. Murakami T, Cardones AR, Hwang ST (2004) Chemokine receptors and melanoma metastasis. J Dermatol Sci 36:71–78

    Article  PubMed  CAS  Google Scholar 

  16. Parkin DM (2001) Global cancer statistics in the year 2000. Lancet Oncol 2:533–543

    Article  PubMed  CAS  Google Scholar 

  17. Phillips RJ, Burdick MD, Lutz M, Belperio JA, Keane MP, Strieter RM (2003) The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med 167:1676–1686

    Article  PubMed  Google Scholar 

  18. Proudfoot AEI (2002) Chemokine receptors: multifaceted therapeutic targets. Nat Rev Immunol 2:106–115

    Article  PubMed  CAS  Google Scholar 

  19. Rosell R, Felip E, Garcia-Campelo R, Balaña C (2004) The biology of non-small-cell lung cancer: identifying new targets for rational therapy. Lung Cancer 46:135–148

    Article  PubMed  CAS  Google Scholar 

  20. Samara G, Lawrence D, Chiarelli CJ, Valentino MD, Lyubsky S, Zucker S, Vaday GG (2004) CXCR4-mediated adhesion and MMP-9 secretion in head and neck squamous cell carcinoma. Cancer Lett 214:231–241

    Article  PubMed  CAS  Google Scholar 

  21. Schrader A, Lechner O, Templin M, Dittmar K, Machtens S, Mengel M, Probst-Kepper M, Franzke A, Wollensak T, Gatzlaff P, Atzpodien J, Buer J, Lauber J (2002) CXCR4/CXCL12 expression and signalling in kidney cancer. Br J Cancer 86:1250–1256

    Article  PubMed  CAS  Google Scholar 

  22. Soriano Á, Martínez C, García F, Plana M, Palou E, Lejeune M, Aróstegui JI, Lazzari ED, Rodriguez C, Barrasa A, Lorenzo JI, Alcamí J, Romero Jd, Miró JM, Gatell JM, Gallart T (2002) Plasma stromal cell-derived factor (SDF)-1 levels, SDF1-3’A genotype, and expression of CXCR4 on T lymphocytes: their impact on resistance to human immunodeficiency virus type 1 infection and its progression. J Infect Dis 186:922–931

    Article  PubMed  CAS  Google Scholar 

  23. Strieter RM, belperio JA, Burdick MD, Sharma S, Dubinett SM, Keane MP (2004) CXC chemokines angiogenesis, immunoangiostasis, and metastases in lung cancer. Ann NY Acad Sci 1028:1–10

    Article  Google Scholar 

  24. Winkler C, Modi W, Smith MW, Nelson GW, Wu X, Carrington M, Dean M, Honjo T, Tashiro K, Yabe D, Buchbinder S, Vittinghoff E, Goedert JJ, O’Brien TR, Jacobson LP, Detels R, Donfield S, Willoughby A, Gomperts E, Vlahov D, Phair J, O’Brien SJ (1998) Genetic restriction of AIDS pathogenesis by an SDF-1 Chemokine Gene Variant. Sci 279:389–393

    Article  CAS  Google Scholar 

  25. Zafiropoulos A, Crikas N, Passam AM, spandidos DA (2004) Significant involvement of CCR2-64I and CXCL12-3’A in the development of sporadic breast cancer. J Med Genet 41:e59

    Article  PubMed  CAS  Google Scholar 

  26. Zlotnik A (2004) Chemokines in neoplastic progression. Semin Cancer Biol 14:181–185

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors thank the Liga Portuguesa Contra O Cancro—Centro Regional Do Norte for their support. The authors would like to thank Fundação Astrazeneca for their support.

Author information

Authors and Affiliations

  1. Molecular Oncology Unit and Radiotherapy Department, Portuguese Institute of Oncology, R. Dr. António Bernardino de Almeida, 4200–072, Porto, Portugal

    Ana Coelho, Carmen Calçada, Raquel Catarino, Daniela Pinto, Graça Fonseca & Rui Medeiros

Authors
  1. Ana Coelho
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carmen Calçada
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Raquel Catarino
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daniela Pinto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Graça Fonseca
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rui Medeiros
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rui Medeiros.

Additional information

Communicated by 05-0068.R2

Rights and permissions

Reprints and permissions

About this article

Cite this article

Coelho, A., Calçada, C., Catarino, R. et al. CXCL12-3′A Polymorphism and lung cancer metastases protection: new perspectives in immunotherapy?. Cancer Immunol Immunother 55, 639–643 (2006). https://doi.org/10.1007/s00262-005-0062-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00262-005-0062-1

Keywords

Search

Navigation